Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Maryam Taghdiri
Observed names:
M. TAGHDIRI,
Taghdiri, Maryam
Institutions:
Razi Vaccine and Serum Research Institute,
Agricultural Research & Education Organization
Observed institutions:
Ahvaz Jundishapur University of Medical Sciences,
Razi Vaccine and Serum Research Institute,
University of Freiburg,
University Medical Center Freiburg,
Agricultural Research & Education Organization
ORCID:
0000-0002-6825-9006
Observed ORCID:
0000-0002-6825-9006
OpenAlex ID:
A5000042759
Viral and Non-Viral Systems to Deliver Gene Therapeutics to Clinical Targets
2024
·
Maryam Taghdiri
, Claudio Mussolino
·
International Journal of Molecular Sciences
·
135
Safety and Efficacy of Combined Intramuscular/Intranasal RAZI-COV PARS Vaccine Candidate Against SARS-CoV-2: A Preclinical Study in Several Animal Models
2022
·
Seyed Reza Banihashemi
, Ali Es-haghi
, et al.
·
Frontiers in Immunology
·
50
PDF
Phase II, Safety and Immunogenicity of RAZI Cov Pars (RCP) SARS Cov-2 Vaccine in Adults Aged 18–70 Years; A Randomized, Double-Blind Clinical Trial
2023
·
Arash Mohazzab
, Mohammad Hossein Fallah Mehrabadi
, et al.
·
Journal of Pharmaceutical Sciences
·
15
Immunogenicity and Safety of a Combined Intramuscular/Intranasal Recombinant Spike Protein COVID-19 Vaccine (RCP) in Healthy Adults Aged 18 to 55 Years Old: A Randomized, Double-Blind, Placebo-Controlled, Phase I Trial
2023
·
Masoud Solaymani Dodaran
, Seyed Reza Banihashemi
, et al.
·
Vaccines
·
15
PDF
Concomitant Increase of OX40 and FOXP3 transcripts in peripheral blood of patients with breast cancer.
2013
·
Maryam Hamidinia
, Mehri Ghafourian Boroujerdnia
, et al.
·
PubMed
·
9
Safety and Immunogenicity of Intranasal Razi Cov Pars as a COVID-19 Booster Vaccine in Adults: Promising Results from a Groundbreaking Clinical Trial
2024
·
Mohammad Hossein Fallah Mehrabadi
, Monireh Hajimoradi
, et al.
·
Vaccines
·
7
PDF
Safety and efficacy of RCP recombinant spike protein covid-19 vaccine compared to Sinopharm BBIBP: A phase III, non-inferiority trial
2024
·
Masoud Solaymani-Dodaran
, Saeed Kalantari
, et al.
·
Heliyon
·
6
Immunogenicity and safety of RAZI recombinant spike protein vaccine (RCP) as a booster dose after priming with BBIBP-CorV: a parallel two groups, randomized, double blind trial
2024
·
Saeed Erfanpoor
, Seyed Reza Banihashemi
, et al.
·
BMC Medicine
·
6
PDF
Development of Enzyme Linked Immunosorbent Assay for humoral immuneresponse and infection monitoring of anthrax
2020
·
H. R. NOURI
, H. RAZZAZ
, et al.
·
Journal of the Hellenic Veterinary Medical Society
·
1
PDF
Anti-inflammatory and Cytotoxic Activities of Sea Cucumber (Holothuria leucospilota) Extract in Colorectal Cancer Cell Line
2018
·
Maryam Taghdiri
, Mohammad‐Ali Assarehzadegan
, et al.
·
Journal of the Persian Gulf (Marine Science)
·
1
Safety and immunogenicity of RAZI Cov Pars (RCP) vaccine in children and adolescents aged 5-17 years: An open-label, single arm trial
2025
·
Mohammad Hossein Fallah Mehrabadi
, Mojtaba Noofeli
, et al.
·
Asian Pacific Journal of Tropical Medicine
Characterization of Luciferase from Photorhabdus kayaii and its Application for In vivo Imaging Studies in Mice
2024
·
Shirin Tarahomjoo
, Laleh Ebrahimi
, et al.
·
Protein and Peptide Letters
Show more works
View as search
Works count:
14
Citation count:
245
H-index:
6
I10-index:
4
Year
Topic
Type